Dataset Information


Genome-wide H3K9 acetylation state before and after VPA treatment

ABSTRACT: Genome-wide maps of the H3K9 acetylation state in embryonic stem cells (ESCs) before and after treatment with low levels of the histone deacetylase (HDAC) inhibitor valproic acid (VPA). ChIP-seq for 3 samples: untreated E14 cells, cells treated with VPA for 4 hrs and cells treated with VPA for 16 hrs. Unprecipitated DNA was used as the input control (Input).

ORGANISM(S): Mus musculus  

SUBMITTER: Eran Meshorer   Hadas Hezroni 

PROVIDER: E-GEOD-24211 | ArrayExpress | 2011-09-17



altmetric image


H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

Hezroni Hadas H   Tzchori Itai I   Davidi Anna A   Mattout Anna A   Biran Alva A   Nissim-Rafinia Malka M   Westphal Heiner H   Meshorer Eran E  

Nucleus (Austin, Tex.) 20110701 4

The pluripotent genome is characterized by unique epigenetic features and a decondensed chromatin conformation. However, the relationship between epigenetic regulation and pluripotency is not altogether clear. Here, using an enhanced MEF/ESC fusion protocol, we compared the reprogramming potency and histone modifications of different embryonic stem cell (ESC) lines (R1, J1, E14, C57BL/6) and found that E14 ESCs are significantly less potent, with significantly reduced H3K9ac levels. Treatment of  ...[more]

Publication: 1/2

Similar Datasets

2011-09-16 | E-GEOD-23957 | ArrayExpress
2011-09-16 | E-GEOD-23958 | ArrayExpress
2011-09-16 | E-GEOD-23956 | ArrayExpress
2011-09-17 | GSE24211 | GEO
2017-09-25 | E-MTAB-4437 | ArrayExpress
2014-10-04 | E-GEOD-56780 | ArrayExpress
2019-07-20 | E-MTAB-6752 | ArrayExpress
2013-04-11 | E-GEOD-31283 | ArrayExpress
2018-02-23 | E-MTAB-5984 | ArrayExpress
2016-04-07 | E-MTAB-3764 | ArrayExpress